Literature DB >> 12847748

Capecitabine induced cutaneous hyperpigmentation: report of a case.

John C Pui1, Shane Meehan, Tibor Moskovits.   

Abstract

We report an unusual case of cutaneous and mucosal hyperpigmentation in a thirty-six year old African American woman who was receiving capecitabine chemotherapy for Stage IV breast carcinoma. Possible etiologies for the hyperpigmentation are discussed. To our knowledge, this is the first reported case of capecitabine associated cutaneous hyperpigmentation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12847748

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  4 in total

1.  Palmar-plantar hyperpigmentation with capecitabine in adjuvant colon cancer.

Authors:  Michael M Vickers; Jacob C Easaw
Journal:  J Gastrointest Cancer       Date:  2009-05-14

2.  Benign dermoscopic parallel ridge pattern in plantar hyperpigmentation due to capecitabine.

Authors:  Linda Tognetti; Michele Fimiani; Pietro Rubegni
Journal:  Dermatol Pract Concept       Date:  2015-04-30

3.  Racial and ethnic differences in capecitabine toxicity in patients with gastrointestinal tract cancers.

Authors:  Alicia Brazelton; Soham Yande; Rita Pope; Michael L Johnson; Benjamin Musher; Meghana V Trivedi
Journal:  Ann Gastroenterol       Date:  2022-02-15

4.  Capecitabine-induced radiation recall phenomenon: a case report.

Authors:  José Aguilar; Elena García; Elisa García-Garre
Journal:  F1000Res       Date:  2012-12-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.